Copyright
©The Author(s) 2018.
World J Virol. Feb 12, 2018; 7(1): 1-9
Published online Feb 12, 2018. doi: 10.5501/wjv.v7.i1.1
Published online Feb 12, 2018. doi: 10.5501/wjv.v7.i1.1
Ref. | Year of publication | Nationality of participants | Sample size | Source of samples | Lab technique | RARβ methylation results |
Virmani et al[57] | 2001 | American | Normal/LSIL = 37 | Normal/LSIL/HSIL from liquid-based cytology specimen | MSP | RARβ methylation positive in |
HSIL = 17 | ICC from biopsy tissue | Normal/LSIL = 11% HSIL = 29% | ||||
ICC = 19 | ICC = 26% | |||||
Narayan et al[56] | 2003 | Colombians | Normal = 8 | Normal = cells from cervical swab LSIL/HSIL = formalin-fixed and paraffin-embedded | MSP | RARβ methylation positive in |
German | LSIL = 9 | cervical tissues | Normal = 0% SCC/AC = 29.3% | |||
American | HSIL = 30 | SCC/AC = tumor biopsies | Immuno-histochemistry of RARβ protein | Immunohistochemistry | ||
SCC = 77 | LSIL; 11% showed low expression | |||||
AC = 5 | HSIL; 60% showed complete lack of expression | |||||
Gustafson et al[37] | 2004 | American | Normal = 11 | Liquid-based cytology specimen | Nested MSP | RARβ methylation positive in |
LSIL = 17 | Normal = 0% LSIL = 0% | |||||
HSIL = 11 | HSIL = 9.1% | |||||
Feng et al[58] | 2005 | Senegalese | Normal/ASCUS = 142 | Exfoliated cervical cells and tissue biopsy | MSP | RARβ methylation positive in |
CIN I = 39 | Normal/ASCUS = 3.2% | |||||
CIN II = 23 | CIN I = 0% | |||||
CIN III = 23 | CIN II = 0% | |||||
ICC = 92 | CIN III = 15.8% ICC = 38.2% | |||||
Wisman et al[59] | 2006 | Dutch | Normal = 19 | Cervical scraping | QMSP | The percentage of RARβ methylation level above control ratio were detected in Normal = 0% SCC = 15% AC = 25% |
SCC = 20 | ||||||
AC = 8 | ||||||
Choi et al[60] | 2007 | Korean | Normal = 37 | Normal cells were from hysterectomy due to myoma | MSP | RARβ methylation positive in |
SCC = 37 | Cancer cells were from tissue after surgery | Immuno-histochemistry of RARβ protein | Normal = 0% SCC = 41% | |||
Immunostaining normal = strong staining | ||||||
SCC = 43% absent staining | ||||||
Zhang et al[52] | 2007 | Japanese and Chinese | Normal = 6 | Cervical tissue by biopsy or surgery | Real-time PCR for RARβ mRNA | RARβ expression level among normal cells: All were highly expressed |
ICC = 17 | RARb2 expression level among cancer cells: | |||||
Semi-nested MSP | 13/17: Completely repressed | |||||
2/17: Highly repressed | ||||||
2/17: Moderately down-regulated | ||||||
Among 13 samples with completely repressed mRNA expression | ||||||
9 promoter methylated, 4 unmethylated | ||||||
Flatley et al[2] | 2009 | English | Normal = 58 | Exfoliated cervical cells and cervical biopsy | Nested MSP | RARβ methylation positive in |
CIN I = 68 | Normal = 6.5% | |||||
CIN II = 56 | CIN I = 42.6% | |||||
CIN III = 76 | CIN II = 6.3% | |||||
ICC = 50 | CIN III = 0% ICC = 15.9% | |||||
Kim et al[54] | 2010 | Korean | Normal = 41 | Liquid based cytology specimen | Multiplex nested MSP | RARβ methylation positive in |
LSIL = 32 | Normal = 4.9% LSIL = 15.6% | |||||
HSIL = 67 SCC = 69 | HSIL = 46.3% SCC = 53.6% | |||||
Kim et al[61] | 2010 | Korean | Normal = 28 | Liquid based cytology specimen | Multiplex QMSP | RARβ methylation level |
LSIL = 26 | Normal = 1.59+3.51% LSIL = 3.67+9.09% | |||||
HSIL = 45 SCC = 63 | HSIL = 21.93+20.10% SCC = 19.06+19.39% | |||||
Yang et al[62] | 2010 | Dutch | Normal = 20 | Biopsy tissue | QMSP | RARβ methylation positive (from tissue) in |
LSIL = 20 | Normal = 85% LSIL = 65% | |||||
HSIL = 20 | Cervical scraping only available in subset of samples | HSIL = 75% SCC = 85% AC = 85% | ||||
SCC = 40 | RARβ methylation positive (from scraping) in | |||||
AC = 20 | Normal = 44% LSIL = 37.5% | |||||
HSIL = 55.6% SCC = 83.8% AC = 100% | ||||||
The median methylation level increased significantly with the severity of lesion (P < 0.05) | ||||||
Pathak et al[63] | 2012 | Indian | Normal = 35 | Normal cells from hysterectomy SIL from excision ICC from tissue biopsy | MSP | RARβ methylation positive in |
SIL = 27 | Normal = 11.4% SIL = 55.5% ICC = 57.8% | |||||
ICC = 38 | ||||||
Milutin Gašperov et al[64] | 2015 | Croatian | Normal = 40 | Cervical scraping | MSP | RARβ methylation positive in |
CIN I = 40 | Normal = 62.5% | |||||
CIN II = 40 | CIN I = 35% | |||||
CIN III = 42 | CIN II = 61.5% | |||||
SCC = 8 AC = 3 | CIN III = 61.9% SCC/AC = 90% | |||||
Sun et al[51] | 2015 | Chinese | Normal = 48 | Liquid based cytology specimen | Methylation specific high resolution melting analysis (Quantitative) | RARβ methylation positive in |
CIN I = 54 | Normal = 31.3% CIN I = 35.2% | |||||
CIN II = 47 | CIN II and III = 28.2% SCC = 33.3% | |||||
CIN III = 56 | RARβ methylation level: none = 68.8% | |||||
SCC = 45 | 0-5% methylation = 26.4% 5-25% = 4.8% |
- Citation: Wongwarangkana C, Wanlapakorn N, Chansaenroj J, Poovorawan Y. Retinoic acid receptor beta promoter methylation and risk of cervical cancer. World J Virol 2018; 7(1): 1-9
- URL: https://www.wjgnet.com/2220-3249/full/v7/i1/1.htm
- DOI: https://dx.doi.org/10.5501/wjv.v7.i1.1